{"prompt": "['Alliance A171601', '57', 'Seymour MT, Thompson LC, Wasan HS, et al. Chemotherapy options in elderly and frail patients', 'with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.', 'Lancet. 2011;377(9779):1749-1759.', '58', 'Atherton, P., et al., What Can Phase I Clinical Trials Tell Us About Quality Of Life? A Pilot', 'Study (Mc0115). Clin Res Trials 1, 2015.', '59', 'Chauhan, C., et al., Patient Satisfaction with Participation in Phase II/III NCCTG Clinical Trials:', 'Was It Worth It? (N0392). J Clin Oncol, 2012. 30(15_Suppl): P. 6133.', '60', 'Chauhan, C., et al., Patient Satisfaction with Participation, Adverse Events and Hospitalizations', 'in Phase II/III NCCTG Clinical Trials: Was It Worth It? (N0392). Quality Of Life Research,', '2012. 21 (Oct2012 Supplement): P. Abstract Nr 202.204.', '61', 'Le-Rademacher, J., et al. Association between Patient Perception of Oncology Clinical Trial', 'Participation and Survival. In Asco Annual Meeting. 2016.', '62', 'Sloan, J., et al. Patient Satisfaction With Participation, Adverse Events And Hospitalizations In', 'Phase II/III NCCTG Clinical Trials: Was It Worth It? In Support Care Cancer. 2012.', '63.', 'Sloan, J., et al. Was It Worth It (WIWI)? Measuring Patient Satisfaction with Clinical Trial', 'Participation. In Support Cancer Care. 2011.', '64', 'Eisenhauer EA, Therasse P, Bogaert J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S,', 'Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J.', 'New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J', 'Cancer 45(2): 228-247, 2009.', '65', 'Kazemi-Bajestani SM, Mazurak VC, Baracos V. Computed tomography-defined muscle and fat', 'wasting are associated with cancer clinical outcomes. Seminars in cell & developmental biology.', '2015.', '66', 'Kim EY, Kim YS, Park I, et al. Evaluation of sarcopenia in small-cell lung cancer patients by', 'routine chest CT. Support Care Cancer. 2016;24(11):4721-4726.', '67', 'Rolland Y, CzerwinskiS, Abellan Van Kan G, et al. Sarcopenia: its assessment, etiology,', 'pathogenesis, consequences and future perspectives. The journal of nutrition, health & aging.', '1008;12(7):433-450.', '68', 'Metter EJ, Conwit R, Tobin J, Fozard JL. Age-associated loss of power and strength in the upper', 'extremities in women and men. The journals of gerontology. Series A, Biological sciences and', 'medical sciences. 097;52(5):B267-276.', '69', 'Evans WJ. Skeletal muscle loss: cachexia, sarcopenia, and inactivity. The American journal of', 'clinical nutrition. 2010;91(4):1123S-1127S.', '70', 'Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle', 'depletion is a powerful prognostic factor, independent of body mass index. Journal of clinical', 'oncology : official journal of the American Society of Clinical Oncology. 2013;31(12):1539-1547.', '71', 'Shachar SS, Deal AM, Weinberg M, et al. Body Composition as a Predictor of Toxicity in', 'Patients Receiving Anthracycline and Taxane Based Chemotherapy for Early Stage Breast', 'Cancer. Clinical cancer research : an official journal of the American Association for Cancer', 'Research. 2017.', '72', 'Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences.', 'American journal of epidemiology. 2005;162(3):199-200.', '73', 'Ershler WB, Sun WH, Binkley N, et al: Interleukin-6 and aging: blood levels and mononuclea', 'cell production increase with advancing age and in vitro production is modifiable by dietary', 'restriction. Lymphokine and cytokine research 12:225-30, 1993', '74', 'Fagiolo U, Cossarizza A, Scala E, et al: Increased cytokine production in mononuclear cells of', 'healthy elderly people. European journal of immunology 23:2375-8, 1993', '75', 'Sindermann J, Kruse A, Frerks HJ, et al: Investigations of the lymphokine system in elderly', 'individuals. Mechanisms of ageing and development 70:149-59, 1993', '80', 'NCIVersion Date: 5/29/2020', 'Update 5']['Alliance A171601', '76', 'Bruunsgaard H, Pedersen M, Pedersen BK: Aging and proinflammatory cytokines. Current', 'opinion in hematology 8:131-6, 2001', '77.', 'Franceschi C, CapriM, MontiD, et al: Inflammaging and anti-inflammaging: a systemic', 'perspective on aging and longevity emerged from studies in humans. Mechanisms of ageing and', 'development 128:92-105, 2007', '78', 'Vasto S, Candore G, Balistreri CR, et al: Inflammatory networks in ageing, age-related diseases', 'and longevity. Mechanisms of ageing and development 128:83-91, 2007', '79', 'Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer', 'cachexia. Nat Rev Clin Oncol. 2013;10(2):90-99.', '80', 'Robson SC, Shephard EG, Kirsch RE: Fibrin degradation product D-dimer induces the synthesis', 'and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from', 'monocytes in vitro. British journal of haematology 86:322-6, 1994', '81', 'Carter RA, Wicks IP: Vascular cell adhesion molecule 1 (CD106): a multifaceted regulator of', 'joint inflammation. Arthritis and rheumatism 44:985-94, 2001', '82', \"Hubbard RE, O'Mahony MS, Savva GM, et al: Inflammation and frailty measures in older\", 'people. Journal of cellular and molecular medicine 13:3103-9, 2009', '83.', 'Cohen HJ, Harris T, Pieper CF: Coagulation and activation of inflammatory pathways in the', 'development of functional decline and mortality in the elderly. The American journal of medicine', '114:180-7, 2003', '84.', 'De Martinis M, Franceschi C, Monti D, et al: Inflammation markers predicting frailty and', 'mortality in the elderly. Experimental and molecular pathology 80:219-27, 2006', '85.', 'de Saint-Hubert M, Jamart J, Morrhaye G, et al: Serum IL-6 and IGF- 1 improve clinical', 'prediction of functional decline after hospitalization in older patients. Aging clinical and', 'experimental research 23:106-11, 2011', '86.', 'FerrucciL, Harris TB, Guralnik JM, et al: Serum IL-6 level and the development of disability in', 'older persons. Journal of the American Geriatrics Society 47:639-46, 1999', '87.', 'FerrucciL, Penninx BW, Volpato S, et al: Change in muscle strength explains accelerated dec line', 'of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc', '50:1947-54, 2002', '88.', 'Huffman KM, Pieper CF, Kraus VB, et al: Relations of a marker of endothelial activation (s-', 'VCAM) to function and mortality in community-dwelling older adults. The journals of', 'gerontology. Series A, Biological sciences and medical sciences 66:1369-75, 2011', '89.', 'Puts MT, Visser M, Twisk JW, et al: Endocrine and inflammatory markers as predictors of', 'frailty. Clin Endocrinol (Oxf) 63:403-11, 2005', '90.', 'Reuben DB, Cheh AI, Harris TB, et al: Peripheral blood markers of inflammation predict', 'mortality and functional decline in high-functioning community-dwelling older persons. Journal', 'of the American Geriatrics Society 50:638-44, 2002', '91', 'Ronning B, Wyller TB, Seljeflot I, et al: Frailty measures, inflammatory biomarkers and post-', 'operative complications in older surgical patients. Age and ageing 39:758-61, 2010', '92', 'Pieper CF, Rao KM, Currie MS, et al: Age, functional status, and racial differences in plasma D-', 'dimer levels in community-dwelling elderly persons. The journals of gerontology. Series A,', 'Biological sciences and medical sciences 55:M649-57, 2000', '81', 'NCIVersion Date: 5/29/2020', 'Update 5']\n\n###\n\n", "completion": "END"}